Supernus hits Zydus with repeat suit over migraine drug

20-09-2021

Muireann Bolger

Supernus hits Zydus with repeat suit over migraine drug

rafapress / Shutterstock.com

Supernus Pharmaceuticals has once again accused Indian generic drugmaker Zydus Cadila and its US unit of allegedly infringing 10 patents with its copycat of Trokendi XR (topiramate), a drug for migraines and seizures.


Supernus, Zydus, Trokendi XR, patents, migraine drug, ANDA

LSIPR